Metraipolis › archive › dc_ecac02be3db2

A surgical window of opportunity trial evaluating the effect of the PCSK9 inhibitor evolocumab on tumoral MHC-I expression and CD8+ infiltration in glioma — Europe PMC PMID:41131134

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/41131134
DOI: 10.1038/s41598-[numero omesso]-9
License (as archived): solo-consultazione
Archived: 2026-11-09T02:43:36.608Z
SHA-256 of the archived text: b459e8995e60bd1149a178b00a2d9386a4341f4464b2d49cdec813a0146d511a
Stable URL of this page: https://metraipolis.com/documento/dc_ecac02be3db2

How to cite

A surgical window of opportunity trial evaluating the effect of the PCSK9 inhibitor evolocumab on tumoral MHC-I expression and CD8+ infiltration in glioma — Europe PMC PMID:41131134 — Europe PMC (en), https://europepmc.org/article/MED/41131134 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_ecac02be3db2 (Metraipolis archive dc_ecac02be3db2, sha256 b459e8995e60bd1149a178b00a2d9386a4341f4464b2d49cdec813a0146d511a)

BibTeX

@misc{dcecac02be3db2,
  title = {A surgical window of opportunity trial evaluating the effect of the PCSK9 inhibitor evolocumab on tumoral MHC-I expression and CD8+ infiltration in glioma — Europe PMC PMID:41131134},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41131134},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_ecac02be3db2; sha256 b459e8995e60bd1149a178b00a2d9386a4341f4464b2d49cdec813a0146d511a},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41131134. Agents can read the archived copy with the MCP tool read_document.